Eagle Bluffs Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Buy |
4,045
+48
| +1% | +$19.5K | 0.78% | 35 |
|
|
2025
Q1 | $1.99M | Sell |
3,997
-1
| -0% | -$498 | 1.05% | 31 |
|
|
2024
Q4 | $2.08M | Buy |
3,998
+284
| +8% | +$148K | 1.12% | 28 |
|
|
2024
Q3 | $2.3M | Buy |
3,714
+23
| +0.6% | +$14.2K | 1.24% | 27 |
|
|
2024
Q2 | $2.04M | Buy |
3,691
+41
| +1% | +$22.7K | 1.19% | 26 |
|
|
2024
Q1 | $2.12M | Buy |
3,650
+38
| +1% | +$22.1K | 1.32% | 26 |
|
|
2023
Q4 | $1.92M | Sell |
3,612
-12
| -0.3% | -$6.37K | 1.31% | 25 |
|
|
2023
Q3 | $1.84M | Sell |
3,624
-354
| -9% | -$179K | 1.41% | 24 |
|
|
2023
Q2 | $2.08M | Buy |
3,978
+52
| +1% | +$27.1K | 1.6% | 21 |
|
|
2023
Q1 | $2.26M | Buy |
3,926
+497
| +14% | +$287K | 1.86% | 17 |
|
|
2022
Q4 | $1.89M | Sell |
3,429
-52
| -1% | -$28.6K | 1.98% | 16 |
|
|
2022
Q3 | $1.77M | Sell |
3,481
-1
| -0% | -$507 | 2.04% | 13 |
|
|
2022
Q2 | $1.89M | Buy |
3,482
+227
| +7% | +$123K | 2.04% | 12 |
|
|
2022
Q1 | $1.92M | Sell |
3,255
-8
| -0.2% | -$4.73K | 1.86% | 13 |
|
|
2021
Q4 | $2.18M | Buy |
+3,263
| New | +$2.18M | 2.27% | 12 |
|